Abstract | OBJECTIVES: MATERIALS AND METHODS: A total of 15 OMFS departments (10 from dental schools, 4 from medical schools, and 1 from a dental hospital) participated in a multi-centric survey. This study assessed every BRONJ case diagnosed between January 2010 and December 2010. The patient age and BP type were evaluated. RESULTS: A total of 254 BRONJ cases were collected. The majority of BRONJ cases were associated with oral BP therapy, while 21.8% of the cases were associated with intravenous administration. Alendronate was the drug most frequently related to BRONJ (59.2% of cases), followed by risedronate (14.3%) and zolendronate (17.0%). The average age of BRONJ patients was 70.0±10.1 years, with a range of 38-88 years of age. With the number of BP patients in Korea reported to be around 600,000 in 2008, the estimated incidence of BRONJ is at least 0.04% or 1 per 2,300 BP patients. CONCLUSION: The results suggest that the estimated incidence of BRONJ in Korea is higher than the incidence of other countries. Future prospective studies should be carried out to investigate the exact epidemiological characteristics of BRONJ in Korea.
|
Authors | Jeong Keun Lee, Kyung-Wook Kim, Jin-Young Choi, Seong-Yong Moon, Su-Gwan Kim, Chul-Hwan Kim, Hyeon-Min Kim, Yong-Dae Kwon, Yong-Deok Kim, Dong-Keun Lee, Seung-Ki Min, In-Sook Park, Young-Wook Park, Min-Suk Kook, Hong-Ju Park, Jin-A Baek, Jun-Woo Park, Tae-Geon Kwon |
Journal | Journal of the Korean Association of Oral and Maxillofacial Surgeons
(J Korean Assoc Oral Maxillofac Surg)
Vol. 39
Issue 1
Pg. 9-13
(Feb 2013)
ISSN: 2234-7550 [Print] Korea (South) |
PMID | 24471011
(Publication Type: Journal Article)
|